Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE2,Angiotensin-converting enzyme 2,48693,163,1.46 [1.17-1.83],0.000747350050109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,49610,166,1.35 [1.07-1.70],0.0109173793222314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTA2,"Actin, aortic smooth muscle",48693,163,1.40 [1.08-1.81],0.0102192550562158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTN2,Alpha-actinin-2,41815,123,1.31 [1.01-1.69],0.0393360181182006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACVRL1,Serine/threonine-protein kinase receptor R3,49142,166,2.19 [1.34-3.57],0.0016716764691252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA2,Adenosine deaminase 2,49318,166,1.56 [1.16-2.11],0.0031694025616301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,41967,124,1.97 [1.37-2.84],0.0002549082655781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,43035,128,1.73 [1.03-2.91],0.0378245674552383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,41967,124,1.67 [1.10-2.55],0.0168615610375977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL2,ADAMTS-like protein 2,43224,130,2.11 [1.38-3.22],0.0005632184044269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL4,ADAMTS-like protein 4,42083,123,2.11 [1.06-4.19],0.0333277325730711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRG1,Adhesion G-protein coupled receptor G1,49371,166,1.16 [1.00-1.34],0.0479192260121796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADIPOQ,Adiponectin,43287,129,1.48 [1.16-1.89],0.001407312628577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADM,Pro-adrenomedullin,50024,168,2.35 [1.39-3.98],0.0014379560425086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRN,Agrin,49821,165,1.83 [1.31-2.54],0.0003657109815856
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR7L,Aflatoxin B1 aldehyde reductase member 4,41967,124,1.27 [1.02-1.57],0.0315999436227589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALCAM,CD166 antigen,50221,168,2.26 [1.16-4.41],0.0169482201027539
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBP,Protein AMBP,49953,168,2.75 [1.44-5.25],0.0021254765524624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT2,Angiopoietin-2,50024,168,2.26 [1.64-3.12],6.431951268557611e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL1,Angiopoietin-related protein 1,48888,162,2.26 [1.41-3.62],0.0007231885917464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL4,Angiopoietin-related protein 4,49744,165,1.77 [1.31-2.39],0.0002299237718556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKRD54,Ankyrin repeat domain-containing protein 54,48422,162,1.29 [1.05-1.57],0.0141412975880029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANPEP,Aminopeptidase N,49725,167,1.78 [1.13-2.81],0.0130668771734179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA2,Annexin A2,41458,123,1.38 [1.14-1.68],0.0012162787249562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA3,Annexin A3,49969,168,1.23 [1.01-1.48],0.0357673526035142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AOC3,Membrane primary amine oxidase,49806,167,1.61 [1.02-2.55],0.0396249437209639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,49866,168,1.31 [1.06-1.61],0.0128748749983804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AREG,Amphiregulin,49371,166,1.87 [1.44-2.44],3.544623822731373e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASGR1,Asialoglycoprotein receptor 1,49224,166,1.76 [1.15-2.71],0.0097279209485127
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATRAID,All-trans retinoic acid-induced differentiation factor,43035,128,1.48 [1.01-2.16],0.0428902955075807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B2M,Beta-2-microglobulin,43287,129,1.51 [1.15-1.98],0.0028771557370637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GALT1,"Beta-1,4-galactosyltransferase 1",49821,165,2.27 [1.43-3.61],0.0005326756483951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,48422,162,1.34 [1.10-1.62],0.0037077982589924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAMBI,BMP and activin membrane-bound inhibitor homolog,48422,162,1.61 [1.06-2.46],0.0272198172141632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAM,Basal cell adhesion molecule,49619,166,1.97 [1.15-3.37],0.0136108561799292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAN,Brevican core protein,49224,166,0.55 [0.37-0.81],0.0023849133211702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCHE,Cholinesterase,42461,125,0.53 [0.33-0.88],0.0133331876181787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMPER,BMP-binding endothelial regulator protein,42273,122,2.07 [1.05-4.08],0.0354041969507859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSG,Basigin,50075,166,2.20 [1.15-4.22],0.0174592443738733
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BST2,Bone marrow stromal antigen 2,50052,168,1.29 [1.02-1.64],0.0323802258977687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN2A1,Butyrophilin subfamily 2 member A1,49821,165,1.82 [1.14-2.91],0.0126583414741976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTNL10,Butyrophilin-like protein 10,41687,124,1.37 [1.03-1.82],0.0278706745518179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C19orf12,Protein C19orf12,48439,166,1.22 [1.03-1.46],0.0250172014361015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QA,Complement C1q subcomponent subunit A,49911,166,2.91 [1.66-5.11],0.0001976490506861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1R,Complement C1r subcomponent,43287,129,2.23 [1.28-3.89],0.0047463785725501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C3,Complement C3,41075,122,1.41 [1.04-1.92],0.0288643205113684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7,Complement component C7,42241,127,3.55 [2.18-5.77],3.22577567220592e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA12,Carbonic anhydrase 12,49371,166,1.71 [1.16-2.51],0.0065615347460498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA8,Carbonic anhydrase-related protein,41967,124,1.54 [1.04-2.29],0.0331521092369543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB1,Calbindin,49371,166,1.42 [1.05-1.94],0.0249690673040572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB2,Calretinin,48439,166,1.36 [1.02-1.80],0.0351026530640985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPG,Macrophage-capping protein,49235,166,1.41 [1.14-1.75],0.0016770436613578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPN3,Calpain-3,43021,127,1.42 [1.03-1.96],0.0348336504200063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLIF,Cobalamin binding intrinsic factor,49536,166,1.20 [1.00-1.43],0.0460992147192995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC134,Coiled-coil domain-containing protein 134,43021,127,1.37 [1.02-1.84],0.0346376713306705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC50,Coiled-coil domain-containing protein 50,43149,126,1.26 [1.05-1.49],0.0104251609382806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC80,Coiled-coil domain-containing protein 80,49610,166,2.18 [1.57-3.01],2.677376029670745e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,42083,123,1.33 [1.03-1.72],0.0285690946190421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL11,Eotaxin,50157,167,1.64 [1.14-2.36],0.0081875274135562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL14,C-C motif chemokine 14,49482,167,1.39 [1.03-1.88],0.0317839587537252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL15,C-C motif chemokine 15,50221,168,1.40 [1.05-1.86],0.022992071178074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL16,C-C motif chemokine 16,50221,168,1.31 [1.00-1.71],0.0480428174788478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL20,C-C motif chemokine 20,50157,167,1.17 [1.03-1.34],0.020147542259239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL21,C-C motif chemokine 21,49821,165,1.52 [1.21-1.93],0.000431583486675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL22,C-C motif chemokine 22,49100,165,1.38 [1.08-1.76],0.0094814374104948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL23,C-C motif chemokine 23,49821,165,1.71 [1.25-2.34],0.0008121879670209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL25,C-C motif chemokine 25,50157,167,1.69 [1.28-2.23],0.0001937920751468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL28,C-C motif chemokine 28,49377,166,1.25 [1.00-1.55],0.0469963724715895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL4,C-C motif chemokine 4,49660,165,1.24 [1.06-1.45],0.0077466309390691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN3,CCN family member 3,50140,168,1.65 [1.15-2.39],0.0071951002201251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN5,CCN family member 5,49619,166,1.73 [1.23-2.45],0.0016667595151385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD14,Monocyte differentiation antigen CD14,48607,165,1.73 [1.28-2.33],0.0003307662438702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD27,CD27 antigen,49753,165,1.55 [1.15-2.09],0.004395701382013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD274,Programmed cell death 1 ligand 1,49224,166,1.73 [1.22-2.46],0.0021392697071787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD276,CD276 antigen,49581,165,2.62 [1.78-3.85],9.00770073767278e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300C,CMRF35-like molecule 6,50052,168,1.53 [1.06-2.21],0.0230203187354454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300E,CMRF35-like molecule 2,49865,168,1.48 [1.09-2.03],0.0128299049122734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300LF,CMRF35-like molecule 1,50024,168,1.28 [1.01-1.62],0.0404236884091335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD302,CD302 antigen,49371,166,1.93 [1.30-2.86],0.0011021503816041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD4,T-cell surface glycoprotein CD4,49456,166,1.56 [1.10-2.22],0.0122451143849617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD48,CD48 antigen,49744,165,1.79 [1.16-2.76],0.0090247140109699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD59,CD59 glycoprotein,47829,159,2.02 [1.21-3.35],0.0069556020351263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5L,CD5 antigen-like,43056,128,1.68 [1.19-2.37],0.0031647645683673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD7,T-cell antigen CD7,41886,124,1.80 [1.30-2.48],0.0003415247356015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD74,HLA class II histocompatibility antigen gamma chain,50052,168,1.81 [1.25-2.61],0.001576606194761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD79B,B-cell antigen receptor complex-associated protein beta chain,50157,167,1.55 [1.19-2.03],0.0011951233396214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99,CD99 antigen,49619,166,2.36 [1.23-4.54],0.0102070401009918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH1,Cadherin-1,47971,160,1.38 [1.02-1.87],0.0356693777011853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH6,Cadherin-6,49610,166,1.54 [1.09-2.17],0.0133716965020133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,49675,165,2.42 [1.32-4.46],0.0044320536136737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,43035,128,0.77 [0.62-0.95],0.0129620407204614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,49537,166,1.23 [1.06-1.43],0.00754603508196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,43224,130,1.51 [1.16-1.97],0.0024559437912194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,48693,163,1.66 [1.31-2.11],3.364000311244422e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEBPB,CCAAT/enhancer-binding protein beta,48693,163,1.46 [1.06-2.02],0.0213214871088058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP290,Centrosomal protein of 290 kDa,42437,128,1.31 [1.03-1.68],0.0277482168076061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFD,Complement factor D,43287,129,2.33 [1.32-4.14],0.0037640495496489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",43118,128,1.96 [1.40-2.73],7.437752739440814e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD6,MICOS complex subunit MIC25,43021,127,1.86 [1.22-2.83],0.0038525120420604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHGA,Chromogranin-A,43224,130,1.19 [1.02-1.40],0.0309581465591622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHI3L1,Chitinase-3-like protein 1,48519,164,1.33 [1.14-1.54],0.000199564962348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL1,Chordin-like protein 1,49744,165,2.02 [1.34-3.06],0.0008713955098345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CILP,Cartilage intermediate layer protein 1,43224,130,1.48 [1.08-2.05],0.016171510052738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CINP,Cyclin-dependent kinase 2-interacting protein,42437,128,0.54 [0.33-0.88],0.0131375505513835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKAP4,Cytoskeleton-associated protein 4,49915,166,2.25 [1.56-3.26],1.5560000578147658e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKB,Creatine kinase B-type,43224,130,1.74 [1.32-2.28],8.31864820527501e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLC,Galectin-10,49534,166,1.22 [1.01-1.48],0.0420498653391433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC11A,C-type lectin domain family 11 member A,49536,166,1.55 [1.16-2.06],0.0025884425060648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC14A,C-type lectin domain family 14 member A,49619,166,1.56 [1.04-2.34],0.0323153697658251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4D,C-type lectin domain family 4 member D,49537,166,1.46 [1.18-1.79],0.0003711033407835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC5A,C-type lectin domain family 5 member A,49448,166,2.04 [1.33-3.12],0.0010560822655655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC6A,C-type lectin domain family 6 member A,48422,162,1.51 [1.15-1.98],0.0027510043619775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLMP,CXADR-like membrane protein,50024,168,2.73 [1.55-4.83],0.0005393182369352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN2,Calsyntenin-2,50157,167,1.88 [1.42-2.47],8.558636118693356e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLU,Clusterin,43287,129,1.54 [1.10-2.17],0.0124641512684058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL18A1,Collagen alpha-1(XVIII) chain,49816,167,3.75 [2.17-6.49],2.238715174130019e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL3A1,Collagen alpha-1(III) chain,43224,130,2.03 [1.06-3.88],0.0318877316208922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A1,Collagen alpha-1(IV) chain,49610,166,2.04 [1.49-2.80],8.173604783828979e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL6A3,Collagen alpha-3(VI) chain,50221,168,2.22 [1.61-3.07],1.2349860097341336e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COLEC12,Collectin-12,49581,165,2.21 [1.38-3.53],0.0009905289172489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO6,Coronin-6,41816,123,1.61 [1.13-2.30],0.0087176114524177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPM,Carboxypeptidase M,49812,167,1.55 [1.06-2.27],0.023269193177698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM2,Inactive carboxypeptidase-like protein X2,43226,128,2.19 [1.36-3.52],0.0012362769541757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIM1,Cysteine-rich motor neuron 1 protein,49821,165,2.28 [1.19-4.36],0.0132405318907807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIP2,Cysteine-rich protein 2,49224,166,1.69 [1.30-2.21],0.0001116017449097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRLF1,Cytokine receptor-like factor 1,49821,165,1.76 [1.02-3.04],0.0428918107555964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1,Macrophage colony-stimulating factor 1,49821,165,2.99 [1.89-4.71],2.5722231901906906e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSRP3,Cysteine and glycine-rich protein 3,41815,123,1.27 [1.10-1.47],0.0008785757886675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST3,Cystatin-C,49726,167,2.20 [1.45-3.33],0.0001964952618159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST7,Cystatin-F,49660,165,1.20 [1.07-1.35],0.0013703186120648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSTB,Cystatin-B,48934,165,1.81 [1.35-2.43],6.521853336181524e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTNNA1,Catenin alpha-1,41816,123,0.46 [0.23-0.93],0.0302468175199604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSB,Cathepsin B,49661,168,1.47 [1.16-1.87],0.0016312506244003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSL,Cathepsin L1,49610,166,2.05 [1.20-3.48],0.008507314410148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSS,Cathepsin S,38986,133,3.01 [1.56-5.82],0.0010634311570636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXADR,Coxsackievirus and adenovirus receptor,49537,166,1.47 [1.15-1.88],0.0020206368617942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL10,C-X-C motif chemokine 10,49821,165,1.25 [1.04-1.51],0.0200749161179146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL13,C-X-C motif chemokine 13,50052,168,1.20 [1.01-1.43],0.036111609138159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL16,C-X-C motif chemokine 16,50140,168,2.97 [1.72-5.14],9.91455994573761e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL17,C-X-C motif chemokine 17,50157,167,1.57 [1.18-2.09],0.001839196628054
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL8,Interleukin-8,49218,166,1.19 [1.00-1.41],0.0437301406387648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL9,C-X-C motif chemokine 9,49821,165,1.40 [1.17-1.68],0.0002153830362103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",49753,165,1.50 [1.03-2.19],0.0364320995796352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",49371,166,1.40 [1.05-1.86],0.0231814271174082
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDR1,Epithelial discoidin domain-containing receptor 1,50052,168,2.34 [1.36-4.04],0.0022831472408947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFA1_DEFA1B,Neutrophil defensin 1,48619,163,1.33 [1.07-1.66],0.0099267508080776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB118,Beta-defensin 118,41816,123,1.34 [1.10-1.63],0.0030706348963534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK4,Dickkopf-related protein 4,49143,166,1.42 [1.09-1.85],0.0104727847820622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL1,Delta-like protein 1,49753,165,1.94 [1.27-2.96],0.0021560147825255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPT,Dermatopontin,50221,168,2.81 [1.58-4.97],0.000409098088761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPY30,Protein dpy-30 homolog,49866,168,1.32 [1.08-1.61],0.0065474839749442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSC2,Desmocollin-2,49059,165,1.89 [1.33-2.69],0.0003609845060719
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG2,Desmoglein-2,49619,166,1.65 [1.01-2.69],0.0439775841310776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTNB,Dystrobrevin beta,42937,127,1.81 [1.29-2.54],0.0005463149089627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX3,Probable E3 ubiquitin-protein ligase DTX3,49371,166,2.53 [1.61-3.95],5.064236460341719e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBI3_IL27,Interleukin-27,49949,168,1.76 [1.15-2.70],0.0092120061525698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECSCR,Endothelial cell-specific chemotaxis regulator,41816,123,0.51 [0.30-0.85],0.0095160509576172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDA2R,Tumor necrosis factor receptor superfamily member 27,50024,168,2.39 [1.77-3.23],1.3370411019877394e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,48693,163,1.52 [1.05-2.21],0.0266934662509906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDN1,Endothelin-1,42083,123,2.72 [1.59-4.64],0.0002460237490802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFCAB14,EF-hand calcium-binding domain-containing protein 14,43035,128,1.59 [1.04-2.42],0.0311611670365051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,49726,167,1.96 [1.30-2.94],0.0012485229628817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA1,Ephrin-A1,49537,165,1.98 [1.29-3.04],0.0017940568319596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA4,Ephrin-A4,49142,166,1.83 [1.25-2.68],0.0017534853859776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFR,Epidermal growth factor receptor,50221,168,0.34 [0.15-0.78],0.0109496171517427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,49610,166,1.26 [1.03-1.54],0.0220137321151878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELN,Elastin,43226,128,2.27 [1.44-3.57],0.0003831553998875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELOA,Elongin-A,49371,166,1.25 [1.03-1.52],0.0265789551393201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENAH,Protein enabled homolog,48668,162,1.47 [1.13-1.92],0.0037246292088933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,48693,163,2.01 [1.14-3.54],0.0151956807439814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA2,Ephrin type-A receptor 2,47811,157,2.12 [1.53-2.94],6.26542512636392e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB4,Ephrin type-B receptor 4,50221,168,2.25 [1.39-3.63],0.0009465862358668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB6,Ephrin type-B receptor 6,49141,166,1.86 [1.25-2.78],0.0024332238551158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPN1,Epsin-1,42437,128,0.46 [0.27-0.79],0.0050945614636545
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,49941,168,1.63 [1.07-2.46],0.0215057480200487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVI2B,Protein EVI2B,41687,124,1.42 [1.05-1.91],0.022122550727225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP1,"Fatty acid-binding protein, liver",49581,165,1.19 [1.04-1.37],0.0130171152774456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP3,"Fatty acid-binding protein, heart",43226,128,1.53 [1.16-2.02],0.0027198697319576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP4,"Fatty acid-binding protein, adipocyte",50221,168,1.60 [1.25-2.04],0.0001563181523232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP5,Fatty acid-binding protein 5,49888,167,1.23 [1.01-1.49],0.042938096779983
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP9,Fatty acid-binding protein 9,49537,166,0.77 [0.60-0.99],0.0416426009523753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM171A2,Protein FAM171A2,43149,126,1.10 [1.00-1.21],0.0451620741911191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3C,Protein FAM3C,49536,166,2.09 [1.37-3.20],0.0006504287055471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FARSA,Phenylalanine--tRNA ligase alpha subunit,42038,121,0.68 [0.50-0.92],0.0120854528104886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRLB,Fc receptor-like B,48422,162,1.31 [1.10-1.56],0.0021360050186791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX1,"Adrenodoxin, mitochondrial",41815,123,1.35 [1.10-1.66],0.003925561627849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FEN1,Flap endonuclease 1,48422,162,1.19 [1.01-1.40],0.0384296391979845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF21,Fibroblast growth factor 21,49949,168,1.16 [1.03-1.29],0.0102931217781396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF23,Fibroblast growth factor 23,49945,168,1.47 [1.22-1.76],4.402618267323449e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF5,Fibroblast growth factor 5,48668,162,1.66 [1.14-2.43],0.0089684784188408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR2,Fibroblast growth factor receptor 2,49753,165,2.17 [1.22-3.85],0.0085108704049201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGL1,Fibrinogen-like protein 1,43258,128,1.50 [1.17-1.92],0.0015613230820364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGR,Tyrosine-protein kinase Fgr,48439,166,1.26 [1.06-1.50],0.0078459729764674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FHIP2A,FHF complex subunit HOOK interacting protein 2A,41815,123,0.64 [0.42-0.98],0.0396465994142932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,49224,166,2.01 [1.28-3.15],0.0025035765365634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT1,Vascular endothelial growth factor receptor 1,49289,166,2.22 [1.47-3.36],0.000157094069635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR2,Folate receptor beta,50052,168,1.79 [1.14-2.80],0.0114724599069875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL3,Follistatin-related protein 3,49505,165,2.36 [1.63-3.42],5.026410824341792e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAP,Gamma-aminobutyric acid receptor-associated protein,43021,127,1.43 [1.09-1.87],0.0101816144076705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,49371,166,1.75 [1.08-2.83],0.023847893393252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS6,Growth arrest-specific protein 6,49899,168,2.31 [1.35-3.95],0.0022927919051198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCG,Pro-glucagon,48422,162,1.16 [1.04-1.29],0.0082987522000963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF15,Growth/differentiation factor 15,50221,168,2.18 [1.79-2.66],1.393996242741746e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GET3,ATPase GET3,43226,128,1.30 [1.00-1.69],0.0491095020782188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFAP,Glial fibrillary acidic protein,48344,161,1.91 [1.47-2.49],1.2549378834276944e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA1,GDNF family receptor alpha-1,49949,168,3.33 [2.22-5.01],7.0811353222989165e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT1,Glutathione hydrolase 1 proenzyme,49537,165,1.45 [1.14-1.85],0.0028316845360331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC2,PDZ domain-containing protein GIPC2,43118,128,2.05 [1.25-3.35],0.0042387618879049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLO1,Lactoylglutathione lyase,48693,163,1.30 [1.03-1.64],0.0260544289896606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GM2A,Ganglioside GM2 activator,42180,128,1.41 [1.04-1.93],0.0283997113887342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,48062,163,1.21 [1.05-1.41],0.0100698317268226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPD1,Glycerol-3-phosphate dehydrogenase,43021,127,1.52 [1.14-2.01],0.0040766381108059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR37,Prosaposin receptor GPR37,48693,163,1.32 [1.07-1.63],0.0096696012799202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPRC5C,G-protein coupled receptor family C group 5 member C,43021,127,1.45 [1.16-1.82],0.0010396166262472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRN,Progranulin,49373,164,1.89 [1.11-3.23],0.019980261534303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRPEL1,"GrpE protein homolog 1, mitochondrial",49371,166,1.33 [1.08-1.64],0.0072609975188214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR1,Hepatitis A virus cellular receptor 1,49953,168,1.37 [1.13-1.67],0.0015245959010577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR2,Hepatitis A virus cellular receptor 2,49619,166,1.84 [1.30-2.62],0.0006600284921059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGF,Hepatoma-derived growth factor,49953,167,1.22 [1.06-1.42],0.0063683800791121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGF,Hepatocyte growth factor,50157,167,2.35 [1.69-3.27],4.691546823677549e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMOX2,Heme oxygenase 2,48439,166,1.31 [1.01-1.69],0.0382135681577526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPGDS,Hematopoietic prostaglandin D synthase,48422,162,0.64 [0.44-0.94],0.0229480322561778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB6,Heat shock protein beta-6,50024,168,2.06 [1.52-2.79],3.6046100861874655e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,49240,165,1.66 [1.04-2.65],0.0329707125538794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTR1B,5-hydroxytryptamine receptor 1B,41816,123,0.53 [0.32-0.88],0.0136868495715915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM1,Intercellular adhesion molecule 1,49399,166,1.77 [1.13-2.76],0.0123588283437411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,41993,126,1.63 [1.10-2.41],0.0157643135260402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR1,Interferon gamma receptor 1,49821,165,2.23 [1.28-3.91],0.0048373585698776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF2R,Cation-independent mannose-6-phosphate receptor,49619,166,1.99 [1.11-3.56],0.0200450714481229
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP1,Insulin-like growth factor-binding protein 1,50138,168,1.13 [1.01-1.26],0.0386813679994131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP2,Insulin-like growth factor-binding protein 2,50142,168,1.82 [1.46-2.28],1.30700909553332e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP4,Insulin-like growth factor-binding protein 4,48983,164,1.91 [1.49-2.44],2.697301453159196e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP7,Insulin-like growth factor-binding protein 7,50221,168,2.19 [1.68-2.85],6.9829053390233124e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBPL1,Insulin-like growth factor-binding protein-like 1,49610,166,1.99 [1.39-2.84],0.000176378453537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLC2,Immunoglobulin lambda constant 2,43212,129,1.84 [1.30-2.59],0.0005146292994789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF3,Immunoglobulin superfamily member 3,49371,166,1.47 [1.06-2.05],0.0200724296888495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15,Interleukin-15,49537,166,2.22 [1.56-3.18],1.1207615754968632e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15RA,Interleukin-15 receptor subunit alpha,48668,162,1.58 [1.06-2.34],0.02325878011368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17C,Interleukin-17C,48668,162,1.23 [1.04-1.46],0.0159278895077834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17D,Interleukin-17D,48668,162,1.38 [1.04-1.85],0.0275270939118918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18,Interleukin-18,49417,165,1.48 [1.12-1.95],0.005755094758282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18BP,Interleukin-18-binding protein,49806,167,1.70 [1.14-2.53],0.0095584608924261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL19,Interleukin-19,48372,162,1.24 [1.04-1.48],0.017355715499741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1B,Interleukin-1 beta,48430,160,1.45 [1.19-1.76],0.0002363691263759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R1,Interleukin-1 receptor type 1,49537,165,2.72 [1.58-4.68],0.0003247472852258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RN,Interleukin-1 receptor antagonist protein,49492,165,1.47 [1.20-1.82],0.0002637989044068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL22,Interleukin-22,43021,127,1.27 [1.01-1.59],0.0377112472804673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RA,Interleukin-2 receptor subunit alpha,49260,167,1.52 [1.12-2.06],0.0066581527018057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RG,Cytokine receptor common subunit gamma,43021,127,1.43 [1.04-1.98],0.0271354458657335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL31,Interleukin-31,41967,124,1.29 [1.02-1.64],0.0339099147061084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL32,Interleukin-32,49537,166,1.39 [1.05-1.86],0.0229109354062713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36G,Interleukin-36 gamma,41812,124,1.27 [1.05-1.54],0.0134485605778703
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4R,Interleukin-4 receptor subunit alpha,49537,166,1.96 [1.43-2.70],3.5314474045349417e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5,Interleukin-5,48668,162,1.13 [1.04-1.22],0.0052679305544701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5RA,Interleukin-5 receptor subunit alpha,49537,166,1.45 [1.15-1.82],0.001451269785495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6,Interleukin-6,49371,166,1.27 [1.11-1.45],0.0006828777099538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6ST,Interleukin-6 receptor subunit beta,49610,166,2.60 [1.26-5.39],0.0100796694471141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL7R,Interleukin-7 receptor subunit alpha,49619,166,0.76 [0.59-0.99],0.0384590104880649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL9,Interleukin-9,42437,128,0.67 [0.45-1.00],0.0487377804026883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMMT,MICOS complex subunit MIC60,43021,127,1.51 [1.11-2.04],0.0077545457419763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INHBB,Inhibin beta B chain,42273,122,1.47 [1.08-2.01],0.0148560120255065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA11,Integrin alpha-11,49537,166,0.53 [0.36-0.79],0.0016831176854458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA2,Integrin alpha-2,42273,122,0.54 [0.33-0.89],0.0164797631225323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAV,Integrin alpha-V,50024,168,0.32 [0.14-0.70],0.0047281559447947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1BP1,Integrin beta-1-binding protein 1,48422,162,1.53 [1.10-2.12],0.0114806205163057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGBL1,Integrin beta-like protein 1,43224,130,1.65 [1.14-2.38],0.0079791418949573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,49806,167,1.75 [1.22-2.51],0.0023594119566153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,43287,129,1.84 [1.06-3.18],0.0294959737390239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM2,Junctional adhesion molecule B,50052,168,1.70 [1.06-2.72],0.0276224880651913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JUN,Transcription factor AP-1,48668,162,1.29 [1.04-1.61],0.0231622681511181
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK11,Kallikrein-11,49275,162,1.46 [1.01-2.10],0.0426423640403857
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK4,Kallikrein-4,50024,168,1.45 [1.20-1.74],9.838410571041502e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT19,"Keratin, type I cytoskeletal 19",49458,166,1.24 [1.03-1.50],0.0261032381652324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,49581,165,1.55 [1.18-2.04],0.0015951798727579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP3,Lysosome-associated membrane glycoprotein 3,50075,166,1.54 [1.20-1.99],0.0007850135589113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAYN,Layilin,49141,166,1.62 [1.14-2.31],0.0074823708464775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LBP,Lipopolysaccharide-binding protein,49806,167,1.31 [1.04-1.65],0.0199657091013193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LECT2,Leukocyte cell-derived chemotaxin-2,43226,128,1.45 [1.14-1.84],0.0021316486028946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS1,Galectin-1,49610,166,1.58 [1.09-2.29],0.0158230311935292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS4,Galectin-4,49581,165,1.34 [1.06-1.68],0.0137978775248768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS7_LGALS7B,Galectin-7,49456,166,1.48 [1.15-1.92],0.0027270678376759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS9,Galectin-9,49583,165,1.78 [1.18-2.67],0.0056881345549477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LHB,Lutropin subunit beta,48422,162,1.16 [1.02-1.33],0.0280002849706509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIFR,Leukemia inhibitory factor receptor,49537,166,2.04 [1.19-3.50],0.009140197380649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,49979,168,1.60 [1.07-2.41],0.022409610744855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,48668,162,1.54 [1.14-2.08],0.0044261558128955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD1,Leiomodin-1,43149,126,2.10 [1.56-2.83],1.1681291556614828e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRG1,Leucine-rich alpha-2-glycoprotein,43287,129,2.16 [1.18-3.95],0.012605437321621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,41819,124,1.80 [1.17-2.77],0.0073413887737102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP11,Low-density lipoprotein receptor-related protein 11,49610,166,1.67 [1.17-2.39],0.0047026797483233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC25,Leucine-rich repeat-containing protein 25,49371,166,1.39 [1.01-1.90],0.0408206257500911
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRN1,Leucine-rich repeat neuronal protein 1,48668,162,0.56 [0.40-0.79],0.001105391318678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,42038,121,1.50 [1.11-2.01],0.0082105949849542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,43149,126,0.49 [0.24-0.99],0.0459395623089667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP2,Latent-transforming growth factor beta-binding protein 2,50221,168,2.43 [1.65-3.59],7.026865176683529e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBR,Tumor necrosis factor receptor superfamily member 3,49336,165,2.02 [1.32-3.09],0.0011053930794107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY6D,Lymphocyte antigen 6D,49330,164,1.48 [1.08-2.04],0.0145228236842737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,49058,166,1.28 [1.03-1.58],0.0227632698067791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGEA3,Melanoma-associated antigen 3,42437,128,0.82 [0.71-0.96],0.0108379457811642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANSC1,MANSC domain-containing protein 1,49753,165,1.81 [1.13-2.92],0.0144654481652016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,41815,123,1.22 [1.01-1.49],0.0401378232491266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN2,Matrilin-2,49664,165,2.40 [1.52-3.79],0.0001596449949036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDK,Midkine,49607,165,1.42 [1.15-1.75],0.0012482196497466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MERTK,Tyrosine-protein kinase Mer,50157,167,2.43 [1.46-4.07],0.0007033412505582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP7,Matrilysin,48615,163,1.79 [1.34-2.40],8.748843103505364e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP8,Neutrophil collagenase,49969,168,1.44 [1.22-1.70],1.562710665910725e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP9,Matrix metalloproteinase-9,49545,166,1.57 [1.25-1.96],9.05978400479025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",41815,123,1.42 [1.05-1.91],0.0209646935520116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MN1,Transcriptional activator MN1,42038,121,0.66 [0.45-0.96],0.0289236754019142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MNDA,Myeloid cell nuclear differentiation antigen,49534,166,1.19 [1.06-1.33],0.0022333895525519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPO,Myeloperoxidase,49619,166,1.47 [1.14-1.89],0.0030581910021061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRC1,Macrophage mannose receptor 1,43258,128,2.09 [1.20-3.66],0.0094519442945952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC13,Mucin-13,48439,166,1.32 [1.02-1.70],0.0344365363278291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC1,"Myosin-binding protein C, slow-type",43226,128,1.31 [1.06-1.61],0.0120354800728836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MZB1,Marginal zone B- and B1-cell-specific protein,49741,165,1.34 [1.04-1.73],0.0232789264296269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBL1,Neuroblastoma suppressor of tumorigenicity 1,49753,165,2.28 [1.42-3.67],0.0006576251160166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAM2,Neural cell adhesion molecule 2,49619,166,1.79 [1.09-2.96],0.0224303032962594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAN,Neurocan core protein,50052,168,0.68 [0.48-0.97],0.0323983828843864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCF2,Neutrophil cytosol factor 2,49457,166,1.22 [1.07-1.40],0.004079520877958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,43035,128,1.61 [1.01-2.59],0.0471869219029571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCS1,Neuronal calcium sensor 1,50024,168,2.59 [1.64-4.09],4.658758498365724e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN2,Nectin-2,49536,166,1.90 [1.25-2.88],0.0026586900464752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEFL,Neurofilament light polypeptide,48287,165,1.85 [1.43-2.40],2.357209990151871e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOP56,Nucleolar protein 56,41815,123,0.78 [0.63-0.97],0.0230906638752675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS1,"Nitric oxide synthase, brain",48439,166,1.33 [1.05-1.68],0.0199774827623533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH3,Neurogenic locus notch homolog protein 3,50221,168,1.57 [1.06-2.33],0.0257603053343835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPC2,NPC intracellular cholesterol transporter 2,42501,128,1.83 [1.26-2.67],0.0016506745543058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPDC1,Neural proliferation differentiation and control protein 1,49610,166,2.12 [1.53-2.94],5.935912424768042e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPB,Natriuretic peptides B,48693,163,1.24 [1.12-1.37],3.104169465080527e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP1,Neuropilin-1,49891,167,1.95 [1.22-3.14],0.0057087806800894
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C1A,Cytosolic 5'-nucleotidase 1A,43118,128,2.06 [1.55-2.74],6.661245333316791e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5E,5'-nucleotidase,49753,165,1.28 [1.01-1.61],0.039082064021147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTproBNP,N-terminal prohormone of brain natriuretic peptide,49610,166,1.28 [1.15-1.42],8.121582010432101e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OCLN,Occludin,43149,126,1.63 [1.16-2.29],0.0049364097976725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGN,Mimecan,49619,166,1.65 [1.22-2.22],0.0011113100012923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLR1,Oxidized low-density lipoprotein receptor 1,49134,164,1.43 [1.18-1.73],0.0002540140022082
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMG,Oligodendrocyte-myelin glycoprotein,49371,166,0.74 [0.61-0.91],0.0040677199202805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ORM1,Alpha-1-acid glycoprotein 1,43132,129,2.98 [1.36-6.53],0.0064090661045768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSCAR,Osteoclast-associated immunoglobulin-like receptor,49664,165,1.76 [1.18-2.63],0.0052553015191276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSM,Oncostatin-M,49303,166,1.43 [1.18-1.73],0.0002091537085777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,41614,124,0.64 [0.44-0.92],0.017789345790035
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM2,Paralemmin-2,43118,128,2.31 [1.64-3.26],1.7979873397288669e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAM,Peptidyl-glycine alpha-amidating monooxygenase,49979,168,1.97 [1.18-3.29],0.0093753717405812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARD3,Partitioning defective 3 homolog,42437,128,0.72 [0.55-0.94],0.0167552096287252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH9,Protocadherin-9,43035,128,0.63 [0.41-0.99],0.0431578981780303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD6,Programmed cell death protein 6,49610,166,1.38 [1.07-1.77],0.0132615061705123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRA,Platelet-derived growth factor receptor alpha,49610,166,1.70 [1.07-2.70],0.0249865326329473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA3,Protein disulfide-isomerase A3,42273,122,1.74 [1.01-3.02],0.0467726344387178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,41967,124,1.54 [1.11-2.12],0.0086897703620079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEPD,Xaa-Pro dipeptidase,43258,128,0.46 [0.25-0.87],0.0175563246798653
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGF,Placenta growth factor,50157,167,2.19 [1.44-3.34],0.0002556925259929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP1,Peptidoglycan recognition protein 1,49979,168,1.65 [1.26-2.17],0.0003350437461451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,49224,166,2.03 [1.29-3.19],0.0022533035241642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI3,Elafin,48970,166,1.49 [1.21-1.83],0.0002026420421798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIGR,Polymeric immunoglobulin receptor,48977,164,2.38 [1.69-3.34],5.842701491125715e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,49619,166,1.96 [1.28-3.00],0.0018213774403264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRA,Paired immunoglobulin-like type 2 receptor alpha,49619,166,1.71 [1.23-2.37],0.0012493090814729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRB,Paired immunoglobulin-like type 2 receptor beta,49610,166,1.36 [1.06-1.75],0.0168141589776361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKD2,Polycystin-2,41815,123,1.34 [1.04-1.74],0.0260466789632783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G15,Phospholipase A2 group XV,49753,165,2.23 [1.38-3.59],0.0010183876446463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAUR,Urokinase plasminogen activator surface receptor,49265,165,4.02 [2.67-6.06],2.6814439370395044e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLG,Plasminogen,42189,127,2.42 [1.29-4.52],0.0056232704087215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLIN1,Perilipin-1,48439,166,1.43 [1.02-2.01],0.0405185933639946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNB2,Plexin-B2,49978,168,1.77 [1.04-3.03],0.0366602176054513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",49371,166,1.40 [1.03-1.90],0.0324039814013695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON1,Serum paraoxonase/arylesterase 1,43258,128,0.51 [0.31-0.85],0.0091281079947834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRAP1,Proline-rich acidic protein 1,43224,130,1.56 [1.01-2.40],0.0449663946250739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PREB,Prolactin regulatory element-binding protein,48668,162,1.61 [1.14-2.28],0.0074069355574765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRELP,Prolargin,49581,165,2.37 [1.32-4.27],0.0039430267788806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG2,Bone marrow proteoglycan,43224,130,1.53 [1.13-2.07],0.0061134336043712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,42038,121,0.49 [0.26-0.93],0.0301709030765253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROK1,Prokineticin-1,49537,166,1.36 [1.08-1.71],0.0097984432772345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRR5,Proline-rich protein 5,41967,124,1.44 [1.07-1.93],0.0152185290055197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS22,Brain-specific serine protease 4,41967,124,1.57 [1.12-2.18],0.0082769060429077
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS8,Prostasin,49417,165,1.48 [1.07-2.03],0.0166600018926364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSAP,Prosaposin,42822,130,1.75 [1.11-2.77],0.0158074544282665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGDS,Prostaglandin-H2 D-isomerase,49236,166,1.62 [1.09-2.40],0.0159305369402243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTN,Pleiotrophin,48693,163,1.35 [1.03-1.77],0.0297853876175477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVR,Poliovirus receptor,50052,168,2.00 [1.45-2.76],2.187634549912402e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYY,Peptide YY,41815,123,1.24 [1.05-1.45],0.0091170092226509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QPCT,Glutaminyl-peptide cyclotransferase,49667,166,2.52 [1.59-3.99],8.005434565972219e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QSOX1,Sulfhydryl oxidase 1,42425,127,1.52 [1.24-1.86],4.824240909906922e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RARRES2,Retinoic acid receptor responder protein 2,49891,167,1.33 [1.03-1.72],0.0313763218837329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASSF2,Ras association domain-containing protein 2,48422,162,1.27 [1.06-1.52],0.0108408423339061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBFOX3,RNA binding protein fox-1 homolog 3,43149,126,1.94 [1.48-2.56],2.19614362511302e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP5,Retinol-binding protein 5,49371,166,1.33 [1.06-1.68],0.0138886602920405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP7,Retinoid-binding protein 7,43035,128,1.29 [1.02-1.64],0.0327376057081463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1A,Lithostathine-1-alpha,49316,165,1.41 [1.11-1.80],0.0048046913055479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1B,Lithostathine-1-beta,50221,168,1.34 [1.09-1.66],0.0064172311702044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3A,Regenerating islet-derived protein 3-alpha,50221,168,1.36 [1.12-1.65],0.001741109188161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG4,Regenerating islet-derived protein 4,49664,165,1.70 [1.34-2.16],1.4438542756976566e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELT,Tumor necrosis factor receptor superfamily member 19L,49619,166,1.89 [1.24-2.89],0.0030889016147548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REN,Renin,49610,166,1.23 [1.06-1.43],0.0062854290577496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,49371,166,0.65 [0.46-0.93],0.0176779740460925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RETN,Resistin,49504,166,1.64 [1.24-2.16],0.0004601549103776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGS8,Regulator of G-protein signaling 8,48668,162,0.71 [0.53-0.94],0.0172572178824239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE6,Ribonuclease K6,42961,128,1.65 [1.18-2.31],0.0033227985906536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASET2,Ribonuclease T2,49988,167,2.09 [1.36-3.22],0.0007646535946442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,49610,166,1.59 [1.04-2.41],0.0309871697551232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO1,R-spondin-1,49224,166,1.64 [1.14-2.37],0.0082067781434622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO3,R-spondin-3,50024,168,2.63 [1.78-3.89],1.2533462027043378e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTKN2,Rhotekin-2,41815,123,1.31 [1.02-1.68],0.0367960748798932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A11,Protein S100-A11,49215,165,1.45 [1.17-1.80],0.0007288644790295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A12,Protein S100-A12,48901,166,1.26 [1.05-1.50],0.011536490817223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A13,Protein S100-A13,41967,124,1.69 [1.15-2.47],0.0074631131824161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAA4,Serum amyloid A-4 protein,43287,129,1.55 [1.17-2.05],0.00233815195421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARA5,Scavenger receptor class A member 5,50052,168,1.56 [1.00-2.42],0.048714787272199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB2,Lysosome membrane protein 2,48282,164,2.12 [1.49-3.01],2.8836764606601527e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF2,Scavenger receptor class F member 2,50052,168,2.38 [1.53-3.69],0.0001115843506647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCG2,Secretogranin-2,49796,168,1.62 [1.09-2.42],0.0177236689725936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRG1,Scrapie-responsive protein 1,43226,128,1.75 [1.06-2.88],0.0281174445011713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4C,Semaphorin-4C,49371,166,1.58 [1.09-2.29],0.0164112500853451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN8,Septin-8,43036,128,1.63 [1.03-2.58],0.0369360104099702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA1,Alpha-1-antitrypsin,42479,129,5.04 [1.24-20.57],0.0241731640563523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA11,Serpin A11,50221,168,2.01 [1.43-2.82],5.1872640346527614e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA4,Kallistatin,42501,126,2.26 [1.12-4.55],0.0230494450573119
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB8,Serpin B8,50157,167,1.22 [1.01-1.47],0.0408069548406248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINF2,Alpha-2-antiplasmin,42473,128,3.55 [1.10-11.47],0.0340144833519583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP1,Secreted frizzled-related protein 1,49061,166,1.71 [1.33-2.21],3.036812641771642e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA2,Pulmonary surfactant-associated protein A2,48422,162,1.51 [1.20-1.91],0.0005183258349403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHISA5,Protein shisa-5,43224,130,1.97 [1.34-2.89],0.000567848802474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC1,Sialoadhesin,49821,165,1.52 [1.12-2.08],0.0079936762943065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC5,Sialic acid-binding Ig-like lectin 5,49619,166,1.16 [1.01-1.32],0.0339553581487584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC8,Sialic acid-binding Ig-like lectin 8,42083,123,1.47 [1.02-2.13],0.0394975617731971
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,49736,168,1.33 [1.03-1.72],0.0291076949306522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF1,Signaling lymphocytic activation molecule,48668,162,1.33 [1.04-1.68],0.0204960032893757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF8,SLAM family member 8,48422,162,1.50 [1.15-1.95],0.0025678428531101
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC1,SPARC-related modular calcium-binding protein 1,50024,168,1.98 [1.36-2.90],0.0004051928303078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC2,SPARC-related modular calcium-binding protein 2,49821,165,1.52 [1.08-2.14],0.0165257730933222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCG,Gamma-synuclein,49224,166,1.51 [1.22-1.86],0.0001244609567194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORBS1,Sorbin and SH3 domain-containing protein 1,43149,126,1.38 [1.01-1.89],0.0424901230158624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK1,Serine protease inhibitor Kazal-type 1,49619,166,1.74 [1.33-2.29],6.085102615209409e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK4,Serine protease inhibitor Kazal-type 4,49537,166,1.32 [1.10-1.60],0.0036529376564427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK6,Serine protease inhibitor Kazal-type 6,50024,168,1.37 [1.05-1.78],0.0188564842166617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT1,Kunitz-type protease inhibitor 1,49454,165,2.03 [1.26-3.25],0.0034183945202057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON1,Spondin-1,49664,165,2.16 [1.60-2.91],3.83049386433931e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON2,Spondin-2,49371,165,2.01 [1.38-2.93],0.0002628344432769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPP1,Osteopontin,50142,168,1.49 [1.12-1.98],0.0067084147350182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRP14,Signal recognition particle 14 kDa protein,49371,166,1.27 [1.03-1.56],0.0265045947610107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPX,Sushi repeat-containing protein SRPX,43226,128,1.96 [1.23-3.13],0.0048432741893741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SULT2A1,Bile salt sulfotransferase,49537,166,1.32 [1.08-1.61],0.0068988011497915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD2,Sushi domain-containing protein 2,49619,166,1.70 [1.10-2.61],0.0167359520403732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACSTD2,Tumor-associated calcium signal transducer 2,43944,144,1.76 [1.19-2.60],0.0045272283831804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAFA5,Chemokine-like protein TAFA-5,49371,166,1.72 [1.22-2.42],0.0019840405523429
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1A,T-cell leukemia/lymphoma protein 1A,49151,166,0.83 [0.73-0.95],0.0067428054992254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN2,Transcobalamin-2,50142,168,1.71 [1.17-2.50],0.0059328462175208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEX101,Testis-expressed protein 101,42038,121,0.69 [0.50-0.95],0.02432727831829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF1,Trefoil factor 1,49381,165,1.24 [1.06-1.44],0.0055162581784631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF2,Trefoil factor 2,49744,165,1.51 [1.22-1.87],0.0001553273721137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF3,Trefoil factor 3,49566,167,1.56 [1.25-1.94],7.877570400102439e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFA,Protransforming growth factor alpha,49537,166,1.53 [1.18-2.00],0.0014574980840861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR2,TGF-beta receptor type-2,49753,165,1.72 [1.22-2.43],0.0020893897749087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS2,Thrombospondin-2,49619,166,1.66 [1.21-2.27],0.0014880636917052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS4,Thrombospondin-4,49644,167,1.60 [1.19-2.15],0.0016602041675473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,49806,167,1.49 [1.10-2.01],0.0099425364238528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP1,Metalloproteinase inhibitor 1,49078,166,1.83 [1.19-2.82],0.005952717491371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP4,Metalloproteinase inhibitor 4,49619,166,1.46 [1.06-1.99],0.0186756040103846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMSB10,Thymosin beta-10,49619,166,1.27 [1.06-1.52],0.0099627959502924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNC,Tenascin,49806,167,1.48 [1.12-1.94],0.0052303922577214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,49224,166,1.84 [1.37-2.45],4.0111612095975647e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,49224,166,1.35 [1.14-1.60],0.0005293657077591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,50157,167,1.56 [1.14-2.15],0.0061819842996815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,49581,165,2.44 [1.61-3.70],2.7258131451660387e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,49753,165,1.67 [1.17-2.39],0.0049762813555372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,49664,165,1.75 [1.33-2.30],5.870044380854451e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,49664,165,1.69 [1.11-2.55],0.0136582806759611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,50024,168,1.73 [1.20-2.50],0.0032342152251103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,49619,166,2.25 [1.54-3.29],2.6984966266471056e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,49619,166,1.53 [1.18-1.98],0.001319077668996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,50075,166,1.47 [1.05-2.05],0.0237652496923757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,49224,166,1.41 [1.14-1.73],0.0013105628454939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,49224,166,1.36 [1.03-1.81],0.0324204315736308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF10,Tumor necrosis factor ligand superfamily member 10,50157,167,0.49 [0.29-0.82],0.0073302708104215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF11,Tumor necrosis factor ligand superfamily member 11,49537,166,0.79 [0.63-0.99],0.0420510703133015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13,Tumor necrosis factor ligand superfamily member 13,49821,165,1.77 [1.08-2.89],0.0231849155255631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,50140,168,1.94 [1.29-2.93],0.0014811761205019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNR,Tenascin-R,49224,166,0.72 [0.52-0.99],0.0441412448925232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSAB1,Tryptase alpha/beta-1,50072,167,1.36 [1.04-1.77],0.0249405327359414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBQLN3,Ubiquilin-3,41815,123,1.46 [1.18-1.81],0.0004922683161257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP28,Ubiquitin carboxyl-terminal hydrolase 28,43118,128,1.49 [1.05-2.09],0.0237241456868611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCAM1,Vascular cell adhesion protein 1,49726,167,1.86 [1.16-2.96],0.0093736041672987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFD,Vascular endothelial growth factor D,50074,166,1.49 [1.02-2.16],0.0380076154756832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VNN2,Vascular non-inflammatory molecule 2,49371,166,1.55 [1.13-2.13],0.0061922705663306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG2,V-set and immunoglobulin domain-containing protein 2,43021,127,1.46 [1.16-1.83],0.0010591800528793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG4,V-set and immunoglobulin domain-containing protein 4,49550,166,1.69 [1.25-2.29],0.0007115471079754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC2,WAP four-disulfide core domain protein 2,47080,155,2.04 [1.54-2.70],6.366863003876852e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",49063,166,0.70 [0.50-0.98],0.0374925811953852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WIF1,Wnt inhibitory factor 1,50024,168,1.89 [1.28-2.79],0.0012671560070591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WNT9A,Protein Wnt-9a,48668,162,1.80 [1.20-2.71],0.0047209563816765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XCL1,Lymphotactin,50024,168,1.30 [1.05-1.62],0.0155902099262493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XG,Glycoprotein Xg,49982,168,1.77 [1.22-2.56],0.0026508695619667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XPNPEP2,Xaa-Pro aminopeptidase 2,49753,165,0.84 [0.74-0.95],0.0070829763112687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YAP1,Transcriptional coactivator YAP1,43118,128,3.02 [1.84-4.95],1.2087852931299509e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF830,Zinc finger protein 830,43021,127,1.26 [1.05-1.50],0.0124305061966841
